Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Montelukast in Critically Ill Infants With Developing Bronchopulmonary Dysplasia
NCT07101640Phase 2Recruiting
- Sponsor
- Duke University
- Start
- Feb 2026
- Primary completion
- Jun 2027
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of montelukast in bronchopulmonary dysplasia (BPD), sponsored by Duke University. Started Feb 2026; status: recruiting.
02
Drugs
montelukast
03
Conditions
bronchopulmonary dysplasia (BPD)
Beyond the preview
Go deeper on NCT07101640.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07101640.